ScreenerHero

ACTI Active Biotech AB (publ)

STO · SE · Healthcare · Biotechnology · activebiotech.com
3.570SEK-3.25%Mkt Cap: 9.00M $P/E: —

Active Biotech AB (publ), a biotechnology company, engages in the research, development, production, marketing, and sale of medical, chemical, and biotechnology products in Sweden. It is developing Tasquinimod, a small m…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap9.00M USD
Enterprise Value5.11M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-3.57M USD
Revenue/Share—
Last Price3.570 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees5
CountrySE
SectorHealthcare
IndustryBiotechnology
ISINSE0029278555
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG0.13
EV/EBITDA-1.64
EV/Revenue—
P/S—
P/B2.62
EPS (TTM)-1.70
EPS (Forward)0.00
52W Range
3.5700% of range17.10
52W High17.10 SEK
52W Low3.570 SEK
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-67.11%
ROA-53.16%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.10M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-21.35%
Net Debt-4.19M USD
Net Debt/EBITDA1.34
Balance Sheet
Debt/Equity0.03
Current Ratio4.34
Quick Ratio4.34
Book Value/Sh1.41 SEK
Cash/Share1.67 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 SEK
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:100
Split DateJun 3, 2026
Analyst Consensus
Rating—
Target (Mean)25.00 SEK
Upside (mean)+600.3%
Target Range25.00 SEK – 25.00 SEK
# Analysts1
Ownership
Shares Out.26.36M
Float20.47M
Insiders16.99%
Institutions6.23%
Technical
SMA 504.798 (-25.6%)
SMA 2005.237 (-31.8%)
Beta1.39
S&P 52W Chg16.45%
Avg Vol (30d)46.21K
Avg Vol (10d)54.86K
Technical Indicators
RSI (14)26.1
MACD-0.3027
MACD Signal-0.2873
MACD Hist.-0.0154
BB Upper4.513 SEK
BB Middle4.045 SEK
BB Lower3.576 SEK
BB Width23.17%
ATR (14)0.2076 SEK
Vol Ratio (20d)0.88x